Xolair
OVERDOSE
The maximum tolerated dose of Xolair (omalizumab) has not been determined. Single intravenous doses of up to 4000 mg have been administered to patients without evidence of dose-limiting toxicities. The highest cumulative dose administered to patients was 44,000 mg over a 20-week period, which was not associated with toxicities.
CONTRAINDICATIONS
Xolair (omalizumab) should not be administered to patients who have experienced a severe hypersensitivity reaction to Xolair (see WARNINGS: Anaphylaxis).
Last reviewed on RxList: 7/24/2007
This monograph has been modified to include the generic and brand name in many instances.
Additional Xolair Information
Xolair - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.







